Wuhan Qirui Pharmaceutical is a high-tech enterprise integrating pharmaceutical production, research and development, and sales, located in Wuhan East Lake Economic and Technological Development Zone. Founded in September 2005, it currently has about 600 employees and a production base of more than 560 mu. The company currently has "Ruigan" (ornithine aspartate series) products. Since its launch, this product has experienced rapid market sales growth, ranking first in sales among similar products in data statistical analysis by the internationally authoritative "IMS" and the Southern Medicine Economic Research Institute of the National Medical Products Administration. Since its founding, the company has clearly formulated and adhered to its own research and development strategy for innovative products, and has established an independent technology center in Pudong, Shanghai. Each year, no less than 10% of sales revenue is invested in product research and development. It has complete research equipment and possesses favorable conditions for early-stage new drug research and development and testing. The company has also invested in building a standalone new R&D center at the Wuhan Optics Valley Biolake Innovation Base. The R&D center has a usable area of more than 5,000 square meters. The company is turning this R&D center into a leading international innovative drug R&D base, providing strong momentum for the company's sustainable development. In the past two years, the company has successively been recognized by relevant national, provincial, and municipal government departments as a "National High-tech Enterprise," a "Hubei Province Technology-based SME Growth Roadmap Plan - Key Cultivated Enterprise," a "Hubei Province Innovative Pilot Enterprise," a "Hubei Province Enterprise Technology Center," a "Hubei Province Listed Reserve Enterprise," and a "Key Taxpayer"...; the "Ornithine Aspartate and Formulations Project" was awarded the "Golden Bridge Award" by the China Market Technology Association. With the goal of creating a leading brand, leading industrial upgrading through internationalization, driven by innovative R&D and marketing, and taking quality as its life, the company actively implements a product differentiation strategy, forming centralized advantages in certain areas of the pharmaceutical market—cost, products, and platform services in terms of technology and market share—thereby forming market exclusivity and brand recognition, and comprehensively building a modern technology-based pharmaceutical enterprise with core competitiveness in China. Qirui's mission: "To build Qirui into a representative of China's pharmaceutical advancement, and to provide high-quality products for human health through our professional services."
What does Wuhan Qirui Technology Development Co., Ltd. require? Who is Wuhan Qirui Technology Development Co., Ltd. hiring? recruitment: 生物/制药/化工/环保类占比最多占31.5%,其次是经营管理类占27.4%. What education can get in at ? 本科占比最多占62.9%,其次是硕士占28.2%. High education required at ? 硕士占28.2%,博士占6.5%. Work experience required at ? 3-5年占比最多占33.9%,其次是5-10年占31.5%. Where are the job locations at ? 武汉占比最多占64.5%,其次是上海占19.4%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows